Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

GPR44 antagonism improves islet survival in a diabetes model

Sep. 28, 2016

Novel hybrid peptides as a promising strategy for type 2 diabetes

Sep. 27, 2016

Novel GLP-1/FGF21 dual agonist in preclinical studies

Sep. 27, 2016

BioMarin Pharmaceutical develops CGS inhibitors

Sep. 27, 2016

Versartis starts phase III trial of somavaratan in children with GHD

Sep. 27, 2016

Antares Pharma reports safety results from phase III trial of Quickshot testosterone

Sep. 27, 2016

Reduced soluble CD93 levels linked to type 2 diabetes

Sep. 26, 2016

FDA grants expanded use approvals for Novartis' canakinumab

Sep. 26, 2016

Phase IIa osteoarthritis study of MIV-711 recommended to continue

Sep. 23, 2016

New zebrafish model displays features of 21-hydroxylase deficiency

Sep. 23, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...